Perennial Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -58.36%
(FY 2023)
- Profit -812.56%
(FY 2023)
- Ebitda 632.66%
(FY 2023)
- Net Worth -68.25%
(FY 2023)
- Total Assets -17.95%
(FY 2023)
About Perennial Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Choudhary, Tanuja, and Sangeeta Jain serve as directors at the Company.
- CIN/LLPIN
U74900DL2009PTC189784
- Company No.
189784
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Perennial Lifesciences Private Limited offer?
Perennial Lifesciences Private Limited offers a wide range of products and services, including Flavours & Aromatics, Dry Powder Flavours, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Industrial Chemicals & Supplies, Chemical Intermediates, Medicinal Plant, Ayurvedic & Herbal Extracts.
Who are the key members and board of directors at Perennial Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Choudhary  | Director | 28-Apr-2009 | Current |
| Tanuja | Additional Director | 13-Aug-2022 | Current |
| Sangeeta Jain | Director Appointed In Casual Vacancy | 27-Sep-2022 | Current |
Financial Performance of Perennial Lifesciences.
Perennial Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 58.36% decrease. The company also saw a substantial fall in profitability, with a 812.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 68.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Perennial Lifesciences?
In 2023, Perennial Lifesciences had a promoter holding of 99.90% and a public holding of 0.10%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vokin Biotech Private LimitedActive 18 years 2 monthsAmit Choudhary, Tanuja and 1 more are mutual person
- Kansal Enterprises Private LimitedActive 14 years 8 months
Amit Choudhary, Tanuja and 1 more are mutual person
- Bumyoung Wellness Private LimitedActive 3 years 1 month
Amit Choudhary, Tanuja and 1 more are mutual person
- Inessa Nutraceuticals Private LimitedActive 3 years 1 month
Amit Choudhary, Tanuja and 1 more are mutual person
- Kanishka Vinyl Private LimitedActive 13 years 4 months
Amit Choudhary, Tanuja and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Perennial Lifesciences?
Perennial Lifesciences has a workforce of 16 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Perennial Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perennial Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
